Lax governmental oversight means many businesses think they can get away with collusion – we show that private enforcement makes a difference.
Carmen Medici is a partner in Robbins Geller Rudman & Dowd LLP’s San Diego office and focuses on complex antitrust class action litigation and unfair competition law. He represents businesses and consumers who are the victims of price-fixing, monopolization, collusion, and other anticompetitive and unfair business practices. Medici specializes in litigation against giants in the financial sector, and has worked on behalf of merchants in payment card cases for a decade.
A veteran of litigation in the credit card industry, Medici is currently representing merchants in In re Payment Card Interchange Fee and Merchant Discount Litigation, a large-scale case charging Visa, MasterCard and the country's major banks with antitrust violations related to the allegedly collusive way rules are set in the industry, including rules requiring payment of ever-increasing interchange fees by merchants. He is also a part of the co-lead counsel team in In re SSA Bonds Antitrust Litig., pending in the Southern District of New York, representing bond purchasers who were defrauded by a brazen price-fixing scheme perpetrated at some of the nation’s largest banks.
In addition, Medici litigates antitrust cases on behalf of various generic drug purchasers who allege big pharmaceutical companies concocted a wide-ranging scheme which has cost consumers and pension funds billions. In federal district court in New Jersey, Medici litigates Lincoln Adventures, LLC v. Those Certain Underwriters at Lloyd’s London, where he represents buyers of insurance in an antitrust action against insurance companies in the London market. He is also a member of the co-lead litigation team in In re Aluminum Warehousing Antitrust Litig., currently on appeal before the Second Circuit. He is also a member of the team in In re Digital Music Antitrust Litig., pending in the Southern District of New York.
In the past, Medici represented athletes in In re NCAA Student-Athlete Name & Likeness Licensing Litig. in the Northern District of California, which culminated in a trial victory for student athletes against the NCAA. He was also on the litigation team in In re Fresh & Process Potatoes Antitrust Litig., which resulted in a multi-million dollar settlement.
In addition, Medici is involved in a number of the Firm’s other major antitrust and consumer actions, including ongoing cases regarding manipulation of commodities prices and certain benchmark financial instruments. He regularly identifies and pursues potential new antitrust matters and drafts complaints on behalf of individual and class plaintiffs.
Medici has been named a “Rising Star” by Super Lawyers Magazine for the past four consecutive years. He graduated from Arizona State University with a Bachelor of Science degree in Business Management and received his Juris Doctor degree from the University of San Diego School of Law.
- Super Lawyer “Rising Star,” 2015-2018
- University of San Diego School of Law, J.D., 2006
- Arizona State University, B.S., 2003
- United States Court of Appeals for the Second Circuit
- United States District Courts for the Northern, Eastern, Central and Southern Districts of
- United States District Court for the Northern District of Illinois (General Bar)
- Robbins Geller Defeats Motion to Dismiss Major Antitrust Action Alleging Conspiracy Among the World’s Largest Gas CompaniesJune 27, 2018
- March 30, 2018
- Plaintiffs Represented by Robbins Geller Overcome Defendants’ Motion to Dismiss in Lloyd’s of London Multidistrict LitigationAugust 25, 2017
- January 20, 2017
- Paul Geller Appointed to Plaintiffs’ Steering Committee in Nationwide Liquid Aluminum Sulfate Antitrust LitigationApril 8, 2016
- 31 Robbins Geller Attorneys Recognized as Super Lawyers and Rising Stars for Their Excellence and Achievements in Law by Super Lawyers MagazineJanuary 20, 2016
- April 21, 2015
- Robbins Geller Defeats Goldman Sachs and JPMorgan’s Motion to Dismiss Claims in Aluminum Antitrust ActionMarch 27, 2015
- February 2, 2015
- January 17, 2014
- July 19, 2012